表紙
市場調查報告書
商品編碼
1033290

基因醫療的全球市場 (2016-2026年):產業規模、佔有率、趨勢、機會、預測 (各用途、終端用戶、地區)

Global Genomic Medicine Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2016-2026 Segmented By Application, By End User, By Region

出版日期: | 出版商: TechSci Research | 英文 119 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

  • 全貌
  • 簡介
  • 目錄
簡介

全球基因醫療的市場,以個人化醫療受到高度關注為背景,在預測期間中預計以高年複合成長率成長。

還有對左右治療、診斷、預後的生物標記的鑑定的興趣高漲,技術進步,也可利用醫藥基因學的各種生物標記的鑑定及監測相關研究擴大,研究的活躍和製藥產業的發展,政府舉措和個人投資增加,醫療保健領域的基因研究的應用增加等要素,也促進該市場的成長。同時,缺乏訓練有素的技術人員,FDA的批准速度較慢,臨床試驗的長期化等,可能會對全球市場成長的成長造成輕微限制。

本報告提供全球基因醫療的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,客戶的迴響分析,市場規模的變化、預測,用途、終端用戶、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等彙整資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 COVID-19的影響

第4章 客戶的迴響

第5章 摘要整理

第6章 全球基因醫療市場預測

  • 市場規模、預測
  • 市場佔有率、預測
    • 各用途
      • 腫瘤
      • 心臟病
      • 內分泌
      • 稀少遺傳性疾病
      • 其他
    • 各終端用戶
      • 醫院、診療所
      • 學術、研究
      • 其他
    • 各企業
    • 各地區
  • 產品市場地圖

第7章 北美的基因醫療市場預測

  • 市場規模、預測
  • 市場佔有率、預測
    • 各用途
    • 各終端用戶
    • 各國

第8章 歐洲的基因醫療市場預測

  • 市場規模、預測
  • 市場佔有率、預測
    • 各用途
    • 各終端用戶
    • 各國

第9章 亞太地區的基因醫療市場預測

  • 市場規模、預測
  • 市場佔有率、預測
    • 各用途
    • 各終端用戶
    • 各國

第10章 南美的基因醫療市場預測

  • 市場規模、預測
  • 市場佔有率、預測
    • 各用途
    • 各終端用戶
    • 各國

第11章 中東、非洲的基因醫療市場預測

  • 市場規模、預測
  • 市場佔有率、預測
    • 各用途
    • 各終端用戶
    • 各國

第12章 市場動態

  • 促進因素
  • 課題

第13章 市場趨勢、展開

第14章 競爭情形

  • Genome Medical, Inc.
  • BioMed Central Ltd
  • Aevi Genomic Medicine, Inc.
  • Congenica Ltd.
  • DEEP GENOMICS
  • Editas Medicine, Inc.
  • Cleveland Clinic

第15章 策略性推薦事項

第16章 關於本公司、免責聲明

目錄
Product Code: 7805

Global genomic medicine market is expected to show robust growth with an impressive CAGR in the forecast period, 2016-2026 on the account of rising inclination for personalized medicine. The market is also subjected to the anticipated growth on the back of rising interest in the biomarkers identification for therapy, diagnosis, and prognosis for personalized medicine development. These methods provide more effectiveness and increase the efficiency for pharmaceuticals and thus drive the future growth of the global genomic medicine market in the upcoming five years. Moreover, advancing technology and the possibility of the extended research for the identification and monitoring of different biomarkers that can be used for pharmacogenomics as well, which also substantiates the growth of the global genomic medicine market in the next five years. Moreover, the increasing research and advancing pharma industry is aiding the growth of the global genomic medicine market in the future five years. Additionally, rising government initiatives, personal investments and increased applications of the genomic studies in the healthcare sector are also supporting the growth of the global genomic medicine market in the future five years. Although, lack of trained technicians, slower FDA approvals, and prolonged processes of the clinical trials may put a mild restraint on the growth of the global genomic medicine market.

Genomic medicines, also known as personal medicine, are the pharmaceutical drugs that are specifically designed with the genomic information from the DNA, and protein profiling and their functionality meanwhile understanding their interaction with the human health. These medicines have the ability to provide the details of typical biological information of individuals and thereby using the information to design the respective patient's treatment processes and pharmaceutical drugs.

The global genomic medicine market is segmented by application, end user, competitive landscape, and regional distribution. Based on application, the market is further fragmented into oncology, cardiology, endocrinology, rare genetic disorders, and others. Oncology sub-segment is anticipated to hold the largest revenue shares of the market and dominate the market segment on the account of rapidly increasing instances of cancer and rising number of cancer patients. Various genomic studies are carried out for the diagnosis, analysis, and prognosis along with the treatment of the cancer cells. Genomic medicines are specialized for cancer patients and its utilization is increasing, thereby supporting the growth of the global genomic medicine market in the upcoming five years.

Companies holding the major shares of the global genomic medicine market are Genome Medical, Inc., BioMed Central Ltd, Aevi Genomic Medicine, Inc., Congenica Ltd., Deep Genomics, Editas Medicine, Inc., Cleveland Clinic, among others. Market players are actively involved in the research and technological development in the product developments. The advanced technology has made it possible for the industry to provide excellent services through genomic medicine. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfy the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Historical Years: 2016 - 2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022 - 2026

Objective of the Study:

  • To analyze the historical growth of the market size of global genomic medicine market from 2016 to 2019.
  • To estimate and forecast the market size of global genomic medicine market from 2020 to 2026 and growth rate until 2026.
  • To classify and forecast global genomic medicine market based on application, end user, competitional landscape, and regional distribution.
  • To identify dominant region or segment in the global genomic medicine market.
  • To identify drivers and challenges for global genomic medicine market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global genomic medicine market.
  • To identify and analyze the profile of leading players operating in global genomic medicine market.
  • To identify key sustainable strategies adopted by market players in global genomic medicine market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and distributors across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures and service providers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of global genomic medicine market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Manufacturers, service providers, end users, and other stakeholders
  • Distributors and suppliers of products & services and other stakeholders
  • Organizations, forums, and alliances related to genomic medicine
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, service providers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global genomic medicine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Genomic Medicine Market, By Application:

Oncology

Cardiology

Endocrinology

Rare Genetic Disorders

Others

  • Genomic Medicine Market, By End User:

Hospitals & Clinics

Academic & Research Institutes

Others

  • Genomic Medicine Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global genomic medicine market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Genomic Medicine Market

4. Voice of Customer

5. Executive Summary

6. Global Genomic Medicine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application (Oncology, Cardiology, Endocrinology, Rare Genetic Disorders, Others)
    • 6.2.2. By End User (Hospitals & Clinics, Academic & Research Institutes, Others)
    • 6.2.3. By Company (2020)
    • 6.2.4. By Region
  • 6.3. Product Market Map

7. North America Genomic Medicine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Genomic Medicine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By End User
    • 7.3.2. Mexico Genomic Medicine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By End User
    • 7.3.3. Canada Genomic Medicine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By End User

8. Europe Genomic Medicine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Genomic Medicine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By End User
    • 8.3.2. Germany Genomic Medicine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By End User
    • 8.3.3. United Kingdom Genomic Medicine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By End User
    • 8.3.4. Italy Genomic Medicine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By End User
    • 8.3.5. Spain Genomic Medicine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By End User

9. Asia-Pacific Genomic Medicine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Genomic Medicine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By End User
    • 9.3.2. India Genomic Medicine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By End User
    • 9.3.3. South Korea Genomic Medicine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By End User
    • 9.3.4. Japan Genomic Medicine Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Application
        • 9.3.4.2.2. By End User
    • 9.3.5. Australia Genomic Medicine Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Application
        • 9.3.5.2.2. By End User

10. South America Genomic Medicine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Genomic Medicine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By End User
    • 10.3.2. Argentina Genomic Medicine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By End User
    • 10.3.3. Colombia Genomic Medicine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By End User

11. Middle East and Africa Genomic Medicine Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Application
    • 11.2.2. By End User
    • 11.2.3. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Genomic Medicine Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Application
        • 11.3.1.2.2. By End User
    • 11.3.2. Saudi Arabia Genomic Medicine Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Application
        • 11.3.2.2.2. By End User
    • 11.3.3. UAE Genomic Medicine Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Application
        • 11.3.3.2.2. By End User
    • 11.3.4. Kuwait Genomic Medicine Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Application
        • 11.3.4.2.2. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Genome Medical, Inc.
  • 14.2. BioMed Central Ltd
  • 14.3. Aevi Genomic Medicine, Inc.
  • 14.4. Congenica Ltd.
  • 14.5. DEEP GENOMICS
  • 14.6. Editas Medicine, Inc.
  • 14.7. Cleveland Clinic

15. Strategic Recommendations

16. About Us & Disclaimer